Gilead Sciences Logo

Gilead Sciences

🇺🇸
GILD
US3755581036

Gilead Sciences is a leading US biopharmaceutical company dedicated to discovering, developing, and marketing innovative medicines. The company focuses on creating treatments for life-threatening diseases such as HIV, viral hepatitis, and cancer, with the overarching goal of improving the lives of patients around the world through its groundbreaking research and therapies.

Next Quarterly Earnings

Thursday, October 22, 2026
CW 43
After-Hours
In 56 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on September 24, 2026

Stock Price

Recap: the latest results

Gilead Sciences (GILD) reported its Q2 2026 results on August 4, 2026, after market close. The company reported revenue of 7803 million USD. The reported earnings per share (EPS) was -6.75 USD, beating the analyst estimate of -7.26 USD by 7.0%. Following the release, the stock price reacted with a move of -2.58%.

Generated automatically from our data — as of 08/13/2026 Read the article →

Frequently asked questions

When will Gilead Sciences report its next quarterly earnings?

Gilead Sciences is scheduled to report its next quarterly earnings on 10/22/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Gilead Sciences last report quarterly earnings?

Gilead Sciences last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -6.75 USD.

How does Gilead Sciences stock react to earnings?

Across its last 5 earnings reports, Gilead Sciences stock moved by ±3.8% on average the following day. The largest reaction was +7.5% on 02/11/2025; 3 of 5 reactions were positive.

How often has Gilead Sciences beaten expectations?

Gilead Sciences has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the Gilead Sciences earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$2.13
Actual:
Q2 2026
Beat
Estimate:-$7.26
Actual:-$6.75
Difference:+$0.51
Price reaction (1 day):-2.6 %
Price reaction (7 days):+0.4 %
Q1 2026
Beat
Estimate:$1.91
Actual:$2.03
Difference:+$0.12
Price reaction (1 day):-2.0 %
Price reaction (7 days):-1.5 %
Q4 2025
Beat
Estimate:$1.81
Actual:$1.86
Difference:+$0.05
Price reaction (1 day):+5.8 %
Price reaction (7 days):+5.5 %
Q3 2025
Beat
Estimate:$2.14
Actual:$2.47
Difference:+$0.33
Price reaction (1 day):+1.1 %
Price reaction (7 days):+4.2 %
Q1 2025
Beat
Estimate:$1.96
Actual:$2.01
Difference:+$0.05
Q4 2024
Estimate:
Actual:
Price reaction (1 day):+7.5 %
Price reaction (7 days):+9.5 %

Earnings statistics

Stock reaction to earnings

±3.8%
Avg. next-day move
+7.5%
Largest move (02/11/2025)
60%
Share of positive reactions
±4.2%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+3.3%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Gilead Sciences
Ticker Symbol
GILD
ISIN
US3755581036
Country
🇺🇸
USA
Sector
Index membership